3 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Immunotherapy: new trials by email Literature Review of Immunotherapy trials Research Report on Immunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases Serplulimab combined with bevacizumab and first-line chemotherapy - Non-small Cell Lung Cancer Stage II, Bevacizumab | Phase 2 / Phase 3 | Completed | Sun Yat-sen University | 40 | 2023-05-14 | 2024-11-13 |
| Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer xintilimab injection, Control - Neoadjuvant Chemoradiation Therapy, Rectal Cancer | Phase 2 / Phase 3 | Completed | Changhai Hospital | 201 | 2022-10-01 | 2026-01-02 |
| Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy specific subcutaneous immunotherapy house dust mite allergoid (Novo-Helisen Depot) - Immunotherapy | Phase 3 | Completed | Johann Wolfgang Goethe University Hospital | 34 | 2004-05-01 | 2007-10-05 |
Asthma (1) · Brain Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Rectal Neoplasms (1)
Lung Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Brain Diseases (1) · Bronchial Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
Bevacizumab (1) · Novo-Helisen Depot (1)
Changhai Hospital (1) · Johann Wolfgang Goethe University Hospital (1) · Sun Yat-sen University (1)
China (2) · Germany (1)
Stefan Zielen, M.D., Ph.D. (1)